Treatment in Pd Patients of Peritonitis Caused by Gram-Positive Organisms with Single Daily Dose of Antibiotics
Open Access
- 1 January 1997
- journal article
- research article
- Published by SAGE Publications in Peritoneal Dialysis International
- Vol. 17 (1) , 91-92
- https://doi.org/10.1177/089686089701700121
Abstract
This study was a retrospective case analysis of treatment results of peritonitis in PD patients caused by gram-positive organisms in two different but comparable periods. Cases were entered, regardless of status of exit site, or whether it was the patient's first or subsequent peritonitis episode. Failure was defined as either recurrence of peritonitis (with same organism within four weeks of cessation of treatment) or the therapeutic decision to remove the catheter. Cefazolin used in doses of 1.5 g once a day intraperitoneally (1.0 g if body weight was < 50 kg) with initial tobramycin until culture results became available resulted in a 77% overall cure rate compared to 74% cure in a similar group treated with vancomycin 2.0 g IP weekly (1.0 g if body weight < 50 kg). Peritonitis caused by methicillin-resistant coagulase-negative staphylococci showed a high failure rate; the change to vancomycin after the initial treatment of these cases would be justified. The cure rate of peritonitis caused by S. aureus is disappointingly low (58% with vancomycin, 67% with cefazolin). This is due to the high rate of exit-site infections with this organism.This publication has 7 references indexed in Scilit:
- A randomized trial of staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampinAmerican Journal of Kidney Diseases, 1996
- Vancomycin-Resistant Staphylococcus aureus: Perspectives on Measures Needed for ControlAnnals of Internal Medicine, 1996
- Surreptitious Use of Antimicrobial Agents by Capd PatientsPeritoneal Dialysis International, 1993
- Co-transfer of vancomycin and other resistance genes fromEnterococcus faecalisNCTC 12201 toStaphylococcus aureusFEMS Microbiology Letters, 1992
- Antimicrobial Treatment of Peritonitis Associated with Continuous Ambulatory Peritoneal DialysisPeritoneal Dialysis International, 1991
- Treatment of Peritonitis in Continuous Ambulatory Peritoneal Dialysis (CAPD) with Intraperitoneal Cefazolin and GentamicinPeritoneal Dialysis International, 1989
- Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysisClinical Pharmacology & Therapeutics, 1983